Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-27 @ 11:42 PM
Study NCT ID:
NCT05872893
Status:
UNKNOWN
Last Update Posted:
2023-07-21
First Post:
2023-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone
Sponsor:
Immune Oncology Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-15
First Submit QC Date:
None
Study First Post Date:
2023-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-20
Last Update Post Date:
2023-07-21
Last Update Post Date Type:
ACTUAL